You just read:

Cannabics Pharmaceuticals Announces Initial Commercialization of Cannabinoids-based Personalized Diagnostics for Cancer Patients

News provided by

Cannabics Pharmaceuticals Inc.

Feb 07, 2017, 09:54 ET